CUE - Cue Biopharma GAAP EPS of -$0.25 beats by $0.03 revenue of $1.7M beats by $0.49M May, 09 2024 06:04 PM Cue Biopharma Inc. 2024-05-09 18:04:24 ET More on Cue Biopharma Cue Biopharma, Inc. (CUE) Q4 2023 Earnings Call Transcript Jefferies starts Cue at buy, cites partnering potential Seeking Alpha’s Quant Rating on Cue Biopharma For further details see: Cue Biopharma GAAP EPS of -$0.25 beats by $0.03, revenue of $1.7M beats by $0.49M